Systemic Lupus Erythematosus Clinical Trials
Systemic Lupus Erythematosus clinical trials study new biologics, small-molecule drugs, and treatment approaches for systemic Lupus Erythematosus and related immune or inflammatory conditions. Corterve gathers actively recruiting Systemic Lupus Erythematosus studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Systemic Lupus Erythematosus studies
- Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsNCT07201558PHASE1AstraZenecaBirmingham, Alabama
- A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesNCT06570798PHASE2AmgenScottsdale, Arizona
- Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus ErythematosusNCT06032923PHASE1, PHASE2National Heart, Lung, and Blood Institute (NHLBI)Bethesda, Maryland
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345PHASE1National Cancer Institute (NCI)Birmingham, Alabama
- Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by QuestionnairesNCT05567198National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Bethesda, Maryland
- Systemic Lupus Erythematosus in Gullah HealthNCT00756769Medical University of South CarolinaCharleston, South Carolina
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseNCT07085104PHASE1Allogene TherapeuticsPhoenix, Arizona
- Study of Systemic Lupus ErythematosusNCT00001372National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Bethesda, Maryland
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus ErythematosusNCT07260877PHASE2Ventus Therapeutics U.S., Inc.Beverly Hills, California
- A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusNCT06617325PHASE3UCB Biopharma SRLAvondale, Arizona
- Development of a Therapeutic Endpoint in Pediatric Rheumatologic ConditionsNCT04833465Children's National Research InstituteWashington D.C., District of Columbia
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.NCT06916806PHASE1AstraZenecaAnniston, Alabama
Systemic Lupus Erythematosus trials by state
Systemic Lupus Erythematosus trials by metro
Frequently asked questions
- How do I find recruiting Systemic Lupus Erythematosus clinical trials?
- Corterve aggregates actively recruiting Systemic Lupus Erythematosus studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Systemic Lupus Erythematosus clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Systemic Lupus Erythematosus clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.